ATE263151T1 - Indolderivate verwendbar als endothelinrezeptorantagonisten - Google Patents

Indolderivate verwendbar als endothelinrezeptorantagonisten

Info

Publication number: ATE263151T1
Authority: AT; Austria
Prior art keywords: receptor antagonists; indole derivatives; endothelin receptor; derivatives usable; usable
Prior art date: 1996-05-09

Application number

AT97920690T

Other languages

English (en)

Inventor

David James Rawson

Kevin Neil Dack

Roger Peter Dickinson

Kim James

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-09

Filing date

1997-04-11

Publication date

2004-04-15

1997-04-11 Application filed by Pfizer filed Critical Pfizer

2004-04-15 Application granted granted Critical

2004-04-15 Publication of ATE263151T1 publication Critical patent/ATE263151T1/de

Links

229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
229940054051 antipsychotic indole derivative Drugs 0.000 title 1
239000002308 endothelin receptor antagonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

AT97920690T 1996-05-09 1997-04-11 Indolderivate verwendbar als endothelinrezeptorantagonisten ATE263151T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9609641.7A GB9609641D0 (en)	1996-05-09	1996-05-09	Compounds useful in therapy
PCT/EP1997/001882 WO1997043260A1 (en)	1996-05-09	1997-04-11	Indole derivatives useful as endothelin receptor antagonists

Publications (1)

Publication Number	Publication Date
ATE263151T1 true ATE263151T1 (de)	2004-04-15

Family

ID=10793387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97920690T ATE263151T1 (de)	1996-05-09	1997-04-11	Indolderivate verwendbar als endothelinrezeptorantagonisten

Country Status (42)

Country	Link
US (4)	US6017945A (de)
EP (1)	EP0901470B1 (de)
JP (1)	JP3245179B2 (de)
KR (1)	KR100331217B1 (de)
CN (1)	CN1124262C (de)
AP (1)	AP830A (de)
AR (1)	AR007030A1 (de)
AT (1)	ATE263151T1 (de)
AU (1)	AU717849B2 (de)
BG (1)	BG102873A (de)
BR (1)	BR9709072A (de)
CA (1)	CA2253876A1 (de)
CO (1)	CO4650036A1 (de)
CZ (1)	CZ292928B6 (de)
DE (1)	DE69728392T2 (de)
DK (1)	DK0901470T3 (de)
DZ (1)	DZ2227A1 (de)
EA (1)	EA001471B1 (de)
ES (1)	ES2218675T3 (de)
GB (1)	GB9609641D0 (de)
HN (1)	HN1997000058A (de)
HR (1)	HRP970249B1 (de)
HU (1)	HUP9901245A3 (de)
ID (1)	ID16878A (de)
IL (1)	IL125903A0 (de)
IS (1)	IS1856B (de)
MA (1)	MA26428A1 (de)
NO (1)	NO312547B1 (de)
NZ (1)	NZ332640A (de)
OA (1)	OA10896A (de)
PE (1)	PE65098A1 (de)
PL (1)	PL329725A1 (de)
PT (1)	PT901470E (de)
SI (1)	SI0901470T1 (de)
SK (1)	SK150398A3 (de)
TN (1)	TNSN97078A1 (de)
TR (1)	TR199802269T2 (de)
TW (1)	TW491838B (de)
UA (1)	UA50767C2 (de)
UY (1)	UY24546A1 (de)
WO (1)	WO1997043260A1 (de)
ZA (1)	ZA973963B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9722287D0 (en)	1997-10-22	1997-12-17	Pfizer Ltd	Compounds useful in therapy
DK1553097T3 (da)	1999-02-10	2010-12-13	Astrazeneca Ab	Quinazolinderivat som angiogeneseinhibitor og mellemprodukter dertil
GB0016162D0 (en) *	2000-06-30	2000-08-23	Cancer Res Campaign Tech	Indole-3-acetic acid derivatives
US20050203166A1 (en) *	2000-06-30	2005-09-15	Cancer Research Technology Limited	Indole-3-acetic acid derivatives
DK1397130T3 (da)	2001-06-20	2007-11-12	Wyeth Corp	Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
TWI224101B (en)	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
ATE331708T1 (de)	2002-12-10	2006-07-15	Wyeth Corp	Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren
DE60327550D1 (de)	2002-12-10	2009-06-18	Wyeth Corp	Substituierte indoloxoacetylaminoessigsäurederivate als inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
DK1569901T3 (da)	2002-12-10	2009-02-16	Wyeth Corp	Aryl-, aryloxy- og alkoxysubstituerede 1H-indol-3-yl-glyoxylsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
UA80453C2 (en)	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
CN1726190A (zh)	2002-12-10	2006-01-25	惠氏公司	作为纤溶酶原激活物抑制剂－1(pai－1)的抑制剂的取代3－羰基－1h－吲哚－1－基乙酸衍生物
BRPI0406883A (pt) *	2003-01-22	2006-01-03	Lilly Co Eli	Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
US7420083B2 (en)	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7332521B2 (en)	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7265148B2 (en)	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7141592B2 (en)	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7163954B2 (en)	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7342039B2 (en)	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7446201B2 (en)	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
US7582773B2 (en)	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7411083B2 (en)	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
US7351726B2 (en)	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7442805B2 (en)	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
US7534894B2 (en)	2003-09-25	2009-05-19	Wyeth	Biphenyloxy-acids
US7268159B2 (en)	2003-09-25	2007-09-11	Wyeth	Substituted indoles
JP2005109006A (ja) *	2003-09-29	2005-04-21	Tdk Corp	高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) *	2003-12-16	2009-02-18	Wyeth Corp	Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
US7605172B2 (en)	2004-08-23	2009-10-20	Wyeth	Thiazolo-naphthyl acids
KR20070055563A (ko)	2004-08-23	2007-05-30	와이어쓰	혈전증 및 심혈관 질병의 치료에 유용한 플라스미노겐활성화제 억제제 타입-1(ｐａｉ-1)의 조절제로서의옥사졸로-나프틸 산
BRPI0514549A (pt)	2004-08-23	2008-06-17	Wyeth Corp	ácidos de pirrol-naftila como inibidores de pai-1
US7683091B2 (en)	2005-08-17	2010-03-23	Wyeth	Substituted indoles and methods of their use
US20100022568A1 (en) *	2006-04-13	2010-01-28	Actelion Pharmaceeuticals Ltd.	Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030206A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
DE102008030207A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
US12343337B2 (en)	2016-09-29	2025-07-01	The Regents Of The University Of California	Compounds for increasing neural plasticity
CN106674065A (zh) *	2016-12-07	2017-05-17	贵州大学	一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) *	2018-10-19	2018-12-05	Inflazome Ltd	Novel processes
BR112021016620A2 (pt)	2019-02-27	2021-11-03	Univ California	Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais
KR20240150417A (ko)	2021-12-15	2024-10-15	델릭스 테라퓨틱스, 인크.	페녹시 및 벤질옥시로 치환된 사이코플라스토겐 및 그의 용도
CN117263832B (zh) *	2023-08-18	2026-02-03	辽宁龙田化工科技有限公司	一种2-氯-4-甲磺酰基苯甲酸合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE638840A (de) *	1962-09-14
GB1255518A (en) *	1968-10-08	1971-12-01	Sumitomo Chemical Co	2-indolylacetic acid derivatives and process for production thereof
US4397079A (en) *	1981-03-30	1983-08-09	International Business Machines Corp.	Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) *	1988-11-14	1993-09-14	The Upjohn Company	α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
EP0548250B1 (de) *	1990-09-10	1996-03-27	Rhone-Poulenc Rorer International (Holdings) Inc.	Substituierte bizyklische arylderivate mit selektiver leukotrien b4 antagonistischer wirkung
ZA939516B (en) *	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
ES2141197T3 (es) *	1993-03-19	2000-03-16	Merck & Co Inc	Derivados del acido fenoxifenilacetico.
GB9317096D0 (en) *	1993-08-17	1993-09-29	Pfizer Ltd	Indoles

1996
- 1996-05-09 GB GBGB9609641.7A patent/GB9609641D0/en active Pending
1997
- 1997-04-01 TW TW086104171A patent/TW491838B/zh not_active IP Right Cessation
- 1997-04-11 DK DK97920690T patent/DK0901470T3/da active
- 1997-04-11 DE DE1997628392 patent/DE69728392T2/de not_active Expired - Fee Related
- 1997-04-11 JP JP54042397A patent/JP3245179B2/ja not_active Expired - Fee Related
- 1997-04-11 AU AU26978/97A patent/AU717849B2/en not_active Ceased
- 1997-04-11 NZ NZ332640A patent/NZ332640A/en unknown
- 1997-04-11 CN CN97194016A patent/CN1124262C/zh not_active Expired - Fee Related
- 1997-04-11 UA UA98115906A patent/UA50767C2/uk unknown
- 1997-04-11 EA EA199800908A patent/EA001471B1/ru not_active IP Right Cessation
- 1997-04-11 PT PT97920690T patent/PT901470E/pt unknown
- 1997-04-11 KR KR1019980709023A patent/KR100331217B1/ko not_active Expired - Fee Related
- 1997-04-11 CA CA002253876A patent/CA2253876A1/en not_active Abandoned
- 1997-04-11 BR BR9709072A patent/BR9709072A/pt active Search and Examination
- 1997-04-11 AT AT97920690T patent/ATE263151T1/de not_active IP Right Cessation
- 1997-04-11 TR TR1998/02269T patent/TR199802269T2/xx unknown
- 1997-04-11 CZ CZ19983582A patent/CZ292928B6/cs not_active IP Right Cessation
- 1997-04-11 ES ES97920690T patent/ES2218675T3/es not_active Expired - Lifetime
- 1997-04-11 EP EP97920690A patent/EP0901470B1/de not_active Expired - Lifetime
- 1997-04-11 WO PCT/EP1997/001882 patent/WO1997043260A1/en not_active Ceased
- 1997-04-11 PL PL97329725A patent/PL329725A1/xx unknown
- 1997-04-11 HU HU9901245A patent/HUP9901245A3/hu unknown
- 1997-04-11 US US09/147,096 patent/US6017945A/en not_active Expired - Fee Related
- 1997-04-11 SK SK1503-98A patent/SK150398A3/sk unknown
- 1997-04-11 SI SI9730646T patent/SI0901470T1/xx unknown
- 1997-04-11 IL IL12590397A patent/IL125903A0/xx unknown
- 1997-04-29 HN HN1997000058A patent/HN1997000058A/es unknown
- 1997-05-02 PE PE1997000345A patent/PE65098A1/es not_active Application Discontinuation
- 1997-05-07 ID IDP971517A patent/ID16878A/id unknown
- 1997-05-07 DZ DZ970074A patent/DZ2227A1/fr active
- 1997-05-07 TN TNTNSN97078A patent/TNSN97078A1/fr unknown
- 1997-05-07 CO CO97024471A patent/CO4650036A1/es unknown
- 1997-05-07 MA MA24599A patent/MA26428A1/fr unknown
- 1997-05-07 AR ARP970101888A patent/AR007030A1/es not_active Application Discontinuation
- 1997-05-07 UY UY24546A patent/UY24546A1/es not_active IP Right Cessation
- 1997-05-08 ZA ZA973963A patent/ZA973963B/xx unknown
- 1997-05-08 AP APAP/P/1997/000982A patent/AP830A/en active
- 1997-05-09 HR HR970249A patent/HRP970249B1/xx not_active IP Right Cessation
1998
- 1998-08-28 IS IS4838A patent/IS1856B/is unknown
- 1998-10-09 OA OA9800192A patent/OA10896A/en unknown
- 1998-10-27 BG BG102873A patent/BG102873A/xx unknown
- 1998-11-09 NO NO19985225A patent/NO312547B1/no not_active IP Right Cessation
1999
- 1999-10-07 US US09/414,361 patent/US6136843A/en not_active Expired - Fee Related
2000
- 2000-04-24 US US09/556,651 patent/US6306852B1/en not_active Expired - Fee Related
2001
- 2001-01-09 US US09/756,835 patent/US6384070B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ID16878A (id)	1997-11-20
SK150398A3 (en)	1999-03-12
CO4650036A1 (es)	1998-09-03
IL125903A0 (en)	1999-04-11
HRP970249B1 (en)	2003-06-30
DZ2227A1 (fr)	2002-12-25
AU717849B2 (en)	2000-04-06
TW491838B (en)	2002-06-21
DE69728392T2 (de)	2005-01-13
HN1997000058A (es)	1997-06-26
EP0901470A1 (de)	1999-03-17
HUP9901245A3 (en)	2002-01-28
US6384070B2 (en)	2002-05-07
CZ292928B6 (cs)	2004-01-14
GB9609641D0 (en)	1996-07-10
US6017945A (en)	2000-01-25
CN1124262C (zh)	2003-10-15
CA2253876A1 (en)	1997-11-20
JPH11508285A (ja)	1999-07-21
UA50767C2 (uk)	2002-11-15
DE69728392D1 (de)	2004-05-06
TNSN97078A1 (fr)	2005-03-15
DK0901470T3 (da)	2004-07-12
US20010014677A1 (en)	2001-08-16
AP9700982A0 (en)	1997-07-31
NO985225D0 (no)	1998-11-09
US6136843A (en)	2000-10-24
EA001471B1 (ru)	2001-04-23
TR199802269T2 (xx)	2001-12-21
AU2697897A (en)	1997-12-05
CZ358298A3 (cs)	1999-08-11
AP830A (en)	2000-05-03
PL329725A1 (en)	1999-04-12
ES2218675T3 (es)	2004-11-16
NO312547B1 (no)	2002-05-27
EA199800908A1 (ru)	1999-06-24
CN1216531A (zh)	1999-05-12
BR9709072A (pt)	1999-08-03
EP0901470B1 (de)	2004-03-31
ZA973963B (en)	1998-11-09
HUP9901245A2 (hu)	1999-08-30
UY24546A1 (es)	2000-09-29
PE65098A1 (es)	1998-10-29
KR20000010879A (ko)	2000-02-25
BG102873A (en)	1999-11-30
NO985225L (no)	1998-11-09
OA10896A (en)	2001-10-11
MA26428A1 (fr)	2004-12-20
JP3245179B2 (ja)	2002-01-07
AR007030A1 (es)	1999-10-13
PT901470E (pt)	2004-07-30
HRP970249A2 (en)	1998-06-30
HK1019149A1 (en)	2000-01-14
NZ332640A (en)	2001-03-30
IS1856B (is)	2003-02-21
WO1997043260A1 (en)	1997-11-20
IS4838A (is)	1998-08-28
KR100331217B1 (ko)	2002-05-09
US6306852B1 (en)	2001-10-23
SI0901470T1 (en)	2004-08-31

Legal Events

Date

Code

Title

Description

2004-10-15

UEP

Publication of translation of european patent specification

Ref document number: 0901470

Country of ref document: EP

2006-01-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE263151T1 (de)	2004-04-15	Indolderivate verwendbar als endothelinrezeptorantagonisten
ATE197300T1 (de)	2000-11-15	Indolderivate als 5-ht rezeptorantagoniste
DE69734833D1 (de)	2006-01-12	Vitronektin rezeptor antagonisten
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
DE69325167D1 (de)	1999-07-08	Kondensierte indol-derivate als 5-ht4-rezeptor-antagonisten
ATE222892T1 (de)	2002-09-15	Pyrimidinderivate als 5ht2c-rezeptorantagonisten
DE69921351D1 (de)	2004-11-25	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
EP0885205A4 (de)	2002-11-27	Fibrinogen-rezeptor-antagonisten
DE59712958D1 (de)	2008-09-25	Substituierte Purinderivate als Vitronectinrezeptor-Antagonisten
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
DK0906294T3 (da)	2003-05-05	Benzoxazinon-dopamin D4-receptor-antagonister
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
EP0929218A4 (de)	2001-05-16	R2y rezeptor antagonisten
ATE196766T1 (de)	2000-10-15	Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
DE69735811D1 (de)	2006-06-08	Piperazinoderivate als neurokinin-antagonisten
ATE228514T1 (de)	2002-12-15	Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
NO972612D0 (no)	1997-06-06	Pyridazoner som endotelinreseptorantagonister
DE69617010D1 (de)	2001-12-20	Isazole derivate als fibrinogen-rezeptor-antagonisten
AU1150999A (en)	1999-05-10	Indole derivative useful as endothelin receptor antagonist
EP0957908A4 (de)	2003-03-12	Antagonisten des fibrinogen rezeptors
TR199601082A3 (tr)	1999-10-21	Entegrin reseptör antagonistleri.
FI963463L (fi)	1996-09-04	Indolijohdannaiset CCK-reseptoriantagonisteina
FI941117A0 (fi)	1994-03-09	Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina